Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bhakti Umesh Hirlekar"'
Autor:
Omkar Londhe, Sayalee Sanjay Mane, Bhakti Umesh Hirlekar, Ajay Subbevarapu, Anjana Elsa Viju, Vaibhav A. Dixit, Swapnil J. Dengale
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 188:54-65
Publikováno v:
Current Organic Chemistry. 25:1194-1223
Green chemistry is an essential part of the organic synthesis chemistry and plays a principal role in saving the environment from harmful and toxic catalysts. Fruit juice catalyzed chemistry is a vital part of green chemistry in which lemon juice pla
Autor:
Bhakti Umesh Hirlekar, Anila Nuthi, Krishan Dev Singh, Upadhyayula Suryanarayana Murty, Vaibhav A. Dixit
Publikováno v:
European Journal of Medicinal Chemistry. 252:115300
Autor:
Meenakshi, Singh, Bhakti Umesh, Hirlekar, Shagufta, Mondal, Suyash, Pant, Devendra K, Dhaked, V, Ravichandiran, Abhijit, Hazra, Yogesh P, Bharitkar
Publikováno v:
Natural product research.
Aims of the study were the phytochemical investigation and chemical transformation of isolated compounds of medicinal plant listed in 'Ayurveda' like
Autor:
Meenakshi Singh, Bhakti Umesh Hirlekar, Shagufta Mondal, Suyash Pant, Devendra K. Dhaked, V. Ravichandiran, Abhijit Hazra, Yogesh P. Bharitkar
Aims of the study were the phytochemical investigation and chemical transformation of isolated compounds of medicinal plant listed in ���Ayurveda��� like Dolichandrone atrovirens, endemic to Indian subcontinents. From chloroform extract o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cabc806b8f242474de9c42726201257
Autor:
Pokhraj Sahu, Upadhyayula Suryanarayana Murty, P. Radhakrishnanand, S. D. Pawar, Roshan M. Borkar, Athira Joseph, Satyanand Konda, Gangasani Jagadeesh Kumar, Pramod Kumar, Daya Raju Adye, Bhakti Umesh Hirlekar, Choppari Thirupathi, Prasad V. Bharatam, Mohana Krishna Reddy Mudiam, Sachin Dubey
Publikováno v:
Drug testing and analysisREFERENCES. 14(2)
Prenylamine was initially used for the treatment of angina pectoris and later on withdrawn from the market in 1988 due to cardiac arrhythmias concern. The major phase I metabolite of prenylamine is p-hydroxy prenylamine that has a chiral center in th